[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-sinopep":3},{"head":4,"company":40,"invest":45,"children":46,"shops":47,"category":48,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":20,"likes":5,"unlikes":5,"follow":5,"pagetitle":21,"pagekeywords":22,"pagedesc":23,"brandContent":24,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":36,"enterWebsite":37,"business":38,"enterQq":5,"enterMail":39,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"118294","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002Ff9f8d1c3bbaa1bc58fb127510d575978.gif","诺泰生物SINOPEP","sinopep",119068,9495,"0571-88671216","2009年","连云港市",709,0,"1","江苏诺泰澳赛诺生物制药股份有限公司",[],"创建于2009年，集医药研发、生产、销售于一体的生物医药上市公司（股票代码：688076），主要从事多肽药物及小分子化药的研发与生产，在江苏和浙江拥有多个研发中心和生产基地，旗下硬胶囊剂、片剂、冻干粉针剂、小容量注射剂和部分原料药已通过国家GMP认证。","诺泰生物SINOPEP简介-诺泰生物原料药-品牌之家","诺泰生物SINOPEP品牌介绍,诺泰生物原料药好不好,诺泰生物怎么样,诺泰生物,江苏诺泰澳赛诺生物制药股份有限公司","诺泰生物SINOPEP品牌简介，品牌之家为你介绍江苏诺泰澳赛诺生物制药股份有限公司旗下诺泰生物SINOPEP品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你诺泰生物原料药怎么样，致力于帮助你了解诺泰生物SINOPEP真实有效的品牌相关信息。","江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药，进行自主研发与定制研发相结合的生物医药企业。公司是国家高新技术企业和省级科技型企业，成立于2009年4月，位于连云港经济技术开发区。公司于2021年5月20日在上海证券交易所科创板挂牌上市（股票简称：诺泰生物，代码：688076），现有员工900余人。\n\n公司致力于通过技术创新，突破药物研发及生产的技术瓶颈，构建从医药高级中间体、原料药到制剂的全产业链，为全球伙伴提供绿色、低成本、优质、高效的医药相关产品和技术服务。\n\n研发方面，公司坚持以技术创新为动力，不断加强自主创新能力建设，连续3年每年投入营业收入总额10％以上的研发费用。公司拥有诺泰生物、澳赛诺、新博思等三个省级研发中心，并组建了一支具有国际技术水平的研发团队，团队现有研发人员160余人，其中硕士、博士共40余人，海归人员6人。研发中心通过整合软硬件条件，实现技术融合，为公司全产业链的业务布局提供了坚实的技术支持。此外，公司还与德国生物化学家—诺贝尔化学奖获得者Hartmut Michel教授合作成立了诺贝尔奖工作站，加速推动公司的技术创新。公司现有授权专利77项，其中发明专利36项，与多个高校和科研院所建立了良好的产学研合作。\n\n生产方面，公司在江苏连云港和浙江建德建立了两个现代化的生产基地，具备了涵盖多肽及小分子化药两大领域、符合国际法规市场标准、覆盖“医药高级中间体—原料药—制剂”全产业链的规模化生产能力。公司的硬胶囊剂、片剂、冻干粉针剂、小容量注射剂和部分原料药已通过国家GMP认证，多肽原料药质量体系于2014年、2016年和2019年先后三次通过了美国FDA的cGMP现场检查。\n\n市场方面，公司坚持国际化战略，通过国际化的品种和业务布局、人才队伍和生产体系建设，使公司产品和技术具备了国际竞争力。经过多年发展，公司凭借先进的研发技术、高标准的质量管理体系，赢得了多个全球知名药企的认可，并建立了长期稳固的合作关系。\n\n未来，公司将以创新驱动发展，不断加大技术创新力度，最终成长为以多肽创新药为主体，以重磅仿制药和技术服务为两翼，具备医药全产业链研发及生产能力的国际知名的生物医药企业。","连云港经济技术开发区临浦路28号","913207006871974358","股份有限公司(上市)","童梓权","2009-04-03","连云港市市场监督管理局","2009-04-03 至 2039-04-02","2022-06-27","21,318.38万(元)","-","冻干粉针剂、小容量注射剂（含非最终灭菌）、原料药、片剂、硬胶囊剂、保健品、医疗器械的生产（均按许可证核定内容经营）；制药技术、生物技术的研发；医药中间体、多肽中间体的生产（药品、保健品、食品、饲料等涉及专项审批的产品除外）；精细化工产品（危险化学品除外）的生产与销售；自营和代理各类商品及技术的进出口业务，但国家限定公司经营或禁止进口的商品和技术除外。（依法须经批准的项目，经相关部门批准后方可开展经营活动）***","0518-85797023","www.sinopep.cn","研究和试验发展","sinopep-hr@sinopep.com",{"enterId":41,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":36,"enterWebsite":37,"business":38,"performance":42,"socialSecurity":43,"registrationNumber":44,"enterQq":5,"enterMail":39,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"119068","开业","702人","320791000034134",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[49],{"createTime":50,"updateTime":51,"createBy":5,"updateBy":5,"industryId":52,"webId":5,"industryName":53,"industryAlias":5,"industryIcon":5,"industryTrans":54,"pageTitle":55,"pageDesc":56,"pageKeywords":57,"mainTitle":58,"pageSubtitle":59,"indSummary":60,"industryLevel":61,"parentId":62,"parentName":5,"sortOrder":63,"status":16,"classifyVisit":5,"totalVisits":64,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-16 16:50:00","9495","原料药","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002Ff9dbfe919674f993814ace696515d139.png","十大原料药生产企业-原料药生产厂家有哪些-ZGALL品牌榜","2026年原料药行业十大品牌权威发布！十大原料药企业排行榜前十名有普洛、联邦、石药、新华、国药现代、丽珠、华海药业、国邦医药、华北制药、九洲。原料药10大厂家排行榜由品牌研究部门收集整理大数据分析研究得出，帮助你了解原料药企业有哪些。","原料药企业排名,原料药企业前十名,十大原料药企业,十大医药中间体公司,化学原料药企业有哪些","原料药品牌排行榜","2026原料药企业排行榜，API原料药-医药中间体公司，化学原料药企业有哪些","原料药哪个好？品牌TOP榜权威发布2026年原料药名录；居前十的有：普洛APELOA、联邦制药、石药CSPC、新华、国药现代、丽珠医药LIVZON、华海药业、国邦医药、华北制药、九洲药业JIUZHOU等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,99,556]